Hologic, Inc. · 8 hours ago
Key Account Manager, Oncology - Mid Atlantic
Hologic, Inc. is a healthcare company specializing in diagnostics, and they are seeking a Key Account Manager for Oncology Diagnostics. The role is responsible for managing relationships with key accounts to grow Breast Cancer Index utilization and ensure commercial performance in the region.
BiotechnologyHealth CareHealth DiagnosticsWomen's
Responsibilities
Manage the total network associated with each identified account
Responsible for the overall commercial performance of a key account, and the development and implementation of project plans to standardize Breast Cancer Index testing
Segment and prioritize accounts as well as identify key players within the accounts
Achieve pre-determined quarterly growth targets across a total network of designated Key Accounts. Quarterly revenue growth will be measured as total revenue increase versus the baseline of historic revenue production within designated accounts in their assigned region
Work with other Hologic stakeholders in the identification and development of additional revenue opportunities as well as the identification of competitor and market activities
Partner with National Sales Directors, Regional Sales Managers, local Oncology Account Executives, and Medical Science Liaisons to build multi-dimensional, powerful corporate relationships with these key target accounts
Monitor progress in key accounts and evolve action plans as appropriate (monitor customer contacts, plan execution, profit, value, volume growth, and market share) work closely with Oncology Account Executives and Regional Manager partners
Qualification
Required
Experience leading large-scale projects with the development of key account plans that achieve sales targets, foster account growth and meet customer expectations
Awareness of oncology pathways and EHR systems within accounts, with tactical knowledge and experience with commercial penetration of each pathway or system
Ability to rapidly acquire knowledge of Hologic product(s) as well as the competitive landscape in the molecular diagnostics industry
Ability to interface with Key Account professionals from other divisions of Hologic to identify areas of synergy or opportunities for co-promotion or collaboration
Excellent verbal and written communication skills, with experience conducting quarterly business reviews to customers/C-suite to assess progress, customer needs/satisfaction, provide solutions and continuous improvement and overall meet customer objectives
Strong business acumen, analytical skills and marketplace knowledge
Be able to take a short, mid and long-term view of the business with key accounts, delivering ongoing opportunities for the portfolio, aligning across all Hologic Business Units, including Breast and Skeletal Health and Surgical divisions when appropriate
BA/BS Degree required
5-10 years of oncology diagnostics, pharmaceutical or biotech sales/marketing experience is required
Experience with Salesforce.com CRM software is required
Preferred
At least 3 years as an Oncology Key Account Manager in a similar capacity is preferred
At least 3 years in a promoted position and/or developmental role with demonstrated leadership across peer and manager groups is preferred
Knowledge of Lean/Six Sigma/Project Management principles preferred
Oncology expertise and experience is preferred
Expertise in Microsoft Windows and Office, specifically Outlook, Word, and PowerPoint, Excel and other popular business software desirable
Company
Hologic, Inc.
We’re an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day.
H1B Sponsorship
Hologic, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (31)
2024 (20)
2023 (15)
2022 (32)
2021 (20)
2020 (14)
Funding
Current Stage
Public CompanyTotal Funding
$2.87B2025-10-21Private Equity
2025-10-21Acquired
2025-07-15Post Ipo Debt· $2.42B
Recent News
2026-01-01
Dallas Morning News
2025-12-26
Company data provided by crunchbase